Home Menu

Prescribing of cannabis-based products

The new regulations to widen the availability of cannabis-based medicinal within the NHS came into effect today, 1 November 2018. Prescribing is restricted to a doctor on the GMC specialist register prescribing within their field of expertise where the cannabis-based product is an unlicensed ‘special’ medicinal product for use by a specific patient. Once a product receives a licence from the MHRA, it will be available for prescription in the same way as any other Schedule 2 drug.

The BMA has published some Q&As to explain what these changes mean, which include links to other guidance including:

Letter from NHS England with guidance on cannabis-based products for medicinal use

Guidance from the British Paediatric Neurology Association on use of cannabis-based products for children with epilepsy

RCP and RCR recommendations on cannabis-based products for medicinal use

NHS England has also published a patient leaflet which helpfully states that ‘You cannot get cannabis-based medicine from your GP - it can only be prescribed by a specialist hospital doctor’

Related guidance...

Cancard Newsletter Article

Cancard Newsletter Article Some concerns have been raised by practices regarding the 'Cancard' website and its proposed 'GP endorsed'...

Prescribing to Vulnerable Adults

A vulnerable adult is defined in 'No Secrets‟ Governments Guidance of Adult Abuse as: 'someone who is aged 18 and over, who is or...

Primary & Secondary Care Interface Guidance

As we know, general practice is facing unprecedented and mounting pressure from rising patient demand and widespread staff shortages. A...

Gender Identity and General Practice

Gender Identity and General Practice Gender Dysphoria Trans Healthcare Gender Identity and General Practice Gender identity issues and...

Primary-Secondary Care Interface

On-going work to implement the NHS Standard Contract In 2015/16 NHS England recognised that general practices were being burdened with...

Updated GMC guidance on prescribing

Updated GMC guidance on prescribing GMC has published updated guidance on prescribing which includes updates regarding remote...

Prescribing at the request of a specialist

Prescribing at the request of a specialist In February 2018 we produced guidance regarding when GPs should and should not prescribe at...

Home Visiting

Visiting patients at home is a part of the GMS contract. The GMS contract states; 7.6.1 In the case of a patient whose medical...

Prescribing Matters Newsletter Article - Medication errors and opiate prescribing

Prescribing Matters Newsletter Article Medication errors and opiate prescribing The LMC is regularly involved in representing and...

Shared Care Update

Monitoring of specialist drugs is an issue which the LMC has been working on for many years. There is not uniformity of provision across...